These observations are consistent with previous studies demonstrating that the knockout of RHBDD2 reduces the apoptosis ratio in cancer cells, indicating the potential of RHBDD2 as a target for conventional chemotherapies [28]. This evidence concerns the gene RHBDD2 and cancer.